#global Pet Insurance market by Application

[omshinde5145]

Image-guided Radiation Therapy (IGRT) Market Share, Sales Channels and Overview Till 2030

The Image-guided Radiation Therapy (IGRT) Market is expected to grow from USD 1.7 billion in 2023-e to USD 2.4 billion by 2030, at a CAGR of 5.3% during the forecast period. Image-Guided Radiation Therapy (IGRT) is an advanced form of radiation therapy that uses imaging techniques to precisely target cancer cells. The image-guided radiation therapy (IGRT) market is expected to grow significantly due to the ability of IGRT to deliver precise doses at the site of action and improve patient outcomes with reduced time of therapy. The accuracy of radiation therapy is increased when cutting-edge imaging technologies are incorporated into the treatment plan. This is especially crucial when treating tumors in motion-prone areas such as the prostate or lungs that are close to important structures.

IGRT is a medical procedure used in radiation oncology to target malignant tumors with therapeutic radiation with the least amount of damage to the surrounding healthy tissues. The integration of imaging technologies with the planning and delivery of radiation therapy treatment is the fundamental component of IGRT. This guarantees that, even in cases where the tumor position varies as a result of factors such as organ motion, anatomical changes in the patient, or respiratory motion, the radiation is precisely targeted to the tumor.

Download a Sample Copy of This Report- https://intentmarketresearch.com/request-sample/image-guided-radiation-therapy-market-3030.html

The IGRT market is influenced by several key factors:

Technological Advancements:

Continuous innovation in imaging and radiation delivery systems is driving the IGRT market forward. Enhanced imaging techniques, such as cone-beam CT, MRI, and PET scans, are enabling more precise tumor localization and treatment planning.

Integration of artificial intelligence (AI) and machine learning (ML) in IGRT systems is further optimizing treatment accuracy and efficiency. AI-powered algorithms can predict tumor movements and adjust radiation doses in real-time, ensuring optimal treatment outcomes.

Rising Cancer Prevalence:

The global burden of cancer is increasing, with millions of new cases diagnosed each year. This rise in cancer incidence is fueling the demand for advanced treatment options like IGRT.

According to the World Health Organization (WHO), the global cancer burden is expected to reach 27.5 million new cases by 2040. This surge underscores the critical need for effective and precise treatments, making IGRT a vital component of modern oncology.

Increased Healthcare Spending:

Governments and healthcare organizations are investing heavily in advanced medical technologies to improve cancer care. This increased funding is facilitating the adoption of IGRT systems in hospitals and cancer treatment centers worldwide.

Public and private healthcare insurers are recognizing the long-term benefits of IGRT in terms of improved patient outcomes and reduced healthcare costs, leading to broader reimbursement policies and greater accessibility.

Growing Awareness and Acceptance:

Awareness campaigns and educational initiatives are highlighting the benefits of IGRT among patients and healthcare providers. As more people become informed about the advantages of this technology, the demand for IGRT is steadily rising.

Professional organizations and regulatory bodies are endorsing IGRT as a standard practice in radiation therapy, further driving its adoption.

Market Segmentation

The IGRT market can be segmented based on technology, application, end-user, and region:

Technology:

Cone-Beam Computed Tomography (CBCT)

Electronic Portal Imaging Devices (EPID)

MRI-guided Radiation Therapy

Positron Emission Tomography (PET)

Application:

Lung Cancer

Prostate Cancer

Breast Cancer

Head and Neck Cancer

Others

End-User:

Hospitals

Ambulatory Radiotherapy Centers

Cancer Research Institutes

Region:

North America

Europe

Asia-Pacific

Latin America

Middle East & Africa

Get Customization on this Report: https://intentmarketresearch.com/ask-for-customization/image-guided-radiation-therapy-market-3030.html

Future Prospects

The future of the IGRT market looks promising, driven by ongoing research and development, technological innovations, and increasing adoption of precision medicine. Key trends to watch in the coming years include:

Advancements in Imaging Technology:

Continuous improvements in imaging modalities will enhance the accuracy and efficacy of IGRT. High-resolution imaging and real-time monitoring will become more sophisticated, allowing for even more precise targeting of tumors.

Integration of AI and ML:

The integration of AI and ML will revolutionize IGRT by enabling adaptive radiation therapy. AI algorithms will predict tumor responses, adjust treatment plans dynamically, and minimize radiation exposure to healthy tissues.

Personalized Cancer Treatment:

Precision medicine will play a crucial role in IGRT, tailoring treatments to individual patients based on genetic profiles, tumor characteristics, and treatment responses. This personalized approach will improve treatment outcomes and reduce side effects.

Global Expansion:

The IGRT market will expand globally, with emerging economies adopting advanced cancer treatment technologies. Increased healthcare infrastructure and government support will drive market growth in regions like Asia-Pacific and Latin America.

Conclusion

Image-Guided Radiation Therapy (IGRT) represents a significant leap forward in cancer treatment, offering unparalleled precision and effectiveness. The IGRT market is poised for substantial growth, driven by technological advancements, rising cancer prevalence, increased healthcare spending, and growing awareness. As we look to the future, continued innovation and integration of cutting-edge technologies will further enhance the capabilities of IGRT, ultimately transforming the landscape of cancer care and improving the lives of countless patients worldwide.

[tamanna31]

Veterinary Orthopedic Medicines Market Poised for Steady Growth in the Future

Veterinary Orthopedic Medicines Industry Overview

The global veterinary orthopedic medicines market size was estimated at USD 1.62 billion in 2023 and is expected to grow at a CAGR of 8.6% from 2024 to 2030.

The growth can be attributed to rising prevalence of orthopedic disorders in animals, the growing uptake of pet insurance, an increase in the aging animal population, and advancements in veterinary orthopedic medicines. Orthopedic issues can negatively impact an animal's quality of life by affecting the bones, muscles, and joints. Canine dysplasia of the elbow & hips and arthritis are among common conditions. Several factors contribute to orthopedic problems in animals, including aging, poor diet, and obesity. Recent studies have shown a rise in obesity among animals such as dogs and horses. For instance, an NCBI study in 2023 on horses revealed a 45% obesity rate.

Gather more insights about the market drivers, restrains and growth of the Veterinary Orthopedic Medicines Market

Stem cell therapy has recently gained popularity and generated significant interest in research & clinical settings. In veterinary medicine, stem cell therapy has been studied as a potential treatment option for various health complications such as dermatological, orthopedic, dental, etc. The use of stem cells in these diseases is still in its infancy, but the potential for stem cell therapy in veterinary medicine is extensive. For instance, StemcellX, a UK-based company, currently has two stem-cell products in the pipeline for application in dogs and horses. The veterinary orthopedic medicines market is growing due to increase in prevalence of Osteoarthritis (OA) and other Degenerative Joint Diseases (DJD) among various animals like dogs, cats, & horses, among others. According to estimates from a 2022 study in Frontiers of Veterinary Sciences, OA is the most common musculoskeletal disorder in dogs, and about 1 in 4 dogs suffer from it. Another research study from the Veterinary Ireland Journal stated that approximately 40% of all cats suffer from OA. Estimates provided by the American Animal Hospital Association (AAHA) reveal that 40% to 92% of cats experience joint pain due to OA or other DJD. Furthermore, the studies suggest possible underdiagnosis of these conditions in these animals. Figures provided by Zoetis indicate that out of the total diagnosed cases of canine OA in the US, only 33% are treated.

Furthermore, University of Illinois data suggests that athletic horses are at a high risk of developing OA that causes lameness. It is estimated that over 50% of horses older than 15 years suffer from OA, and in horses over 30 years of age, this number increases to more than 80% to 90%. OA affects the performance and wellbeing of athletic horses. For early diagnosis, it is important to understand causal & developmental pathways and prescribe the right treatment. Moreover, several pet owners are opting for pet insurance to manage the health expenses of their pets. According to a February 2024 article in USA Today, 26% of surveyed Americans stated they spend between USD 51 & USD 100 a month on their dogs. The same number of people (26%) spend from USD 101 to USD 250 monthly on dog care. Ownership of a dog can cost up to USD 5,000 in some cases. About 66% of the respondents said they had to cut down on their personal expenses to meet the rising costs of owning a pet. Others have taken out loans or asked for financial assistance to pay for the care of animals.

Browse through Grand View Research's Animal Health Industry Research Reports.

The global livestock monitoring market size was estimated at USD 4.01 billion in 2023 and is anticipated to grow at a CAGR of 11.56% from 2024 to 2030. 

The North America and Europe exotic companion animal market size was estimated at USD 1.30 billion in 2023 and is projected to grow at a CAGR of 7.9% from 2024 to 2030.

Key Veterinary Orthopedic Medicines Company Insights

Some of the key players operating in the market are Zoetis Inc; Boehringer Ingelheim; Elanco Animal Health, Inc.; and Merck Animal Health (Merck & Co. Inc). Industry leaders like Zoetis, Inc.; Boehringer Ingelheim; Elanco Animal Health; American Regent, Inc.; Merck Animal Health (Merck & Co. Inc); and Vetoquinol S.A. are investing significantly in the R&D of novel medicines for musculoskeletal complications prevalent in various animals. Companies like Ardent Animal Health, LLC; VetStem, Inc.; and MEDREGO LLC are focusing on developing specialized biologics like stem cells, PRP, and other biologics to effectively combat orthopedic conditions in animals.

Zoetis is one of the leading veterinary product companies in the world. It discovers, develops, manufactures, and commercializes vaccines, medicines, diagnostics, & other technologies for the treatment of various diseases in companion animals, as well as livestock animals. It has a widespread network in over 45 countries.

Elanco Animal Health has operated in the veterinary industry for over 65 years. It is a subsidiary of the pharmaceutical products giant Elli Lilly & Company. The company is among the top four global veterinary product manufacturers, with over 200 brands and a presence in over 90 countries.

Hyalogic, Bioiberica S.A.U, and Contipro A.S. are some of the emerging market participants in the veterinary orthopedic medicines market.

Hyalogic is a company that specializes in and focuses on manufacturing products made from high-molecular-weight hyaluronic acid, which has hydrating and lubricating properties. Its product portfolio includes skin care, personal care, joint care, etc., for humans and specialized joint care products for animals.

Key Veterinary Orthopedic Medicines Companies:

The following are the leading companies in the veterinary orthopedic medicines market. These companies collectively hold the largest market share and dictate industry trends.

Zoetis Inc.

Boehringer Ingelheim

Elanco Animal Health

American Regent, Inc.

Merck Animal Health (Merck & Co. Inc)

Vetoquinol S.A.

Ceva Sante Animale

Virbac

Biogenesis Bago

Ardent Animal Health, LLC

Bioiberica S.A.U

PetVivo Holdings, Inc. (Spryng)

Contipro A.S.

VetStem, Inc.

Enso Discoveries

Contura Vet US

T-Cyte Therepeutics

MEDREGO LLC

Bimeda U.S.

Hyalogic

Hester Biosciences .

Order a free sample PDF of the Veterinary Orthopedic Medicines Market Study, published by Grand View Research.

[industrynewsupdates]

A Comprehensive Guide to Medical Coveralls Procurement Intelligence

The global medical coveralls category is anticipated to grow at a CAGR of 7.4% from 2023 to 2030. The most important PPE in the world was the hooded disposable coveralls in 2020 - 2021. Due to the COVID-19 pandemic, there has been an increase in demand for disposable protective coveralls/apparel because of heightened awareness of self-protection. On a parent level, the PPE category is experiencing tremendous growth due to its industry-agnostic nature and varied applications. The growth of the category is being driven by emerging diseases, such as the September 2022 Ebola outbreak in Uganda and the SARS, new Omicron, and flu variants worldwide. This has increased the need for protection for frontline healthcare workers. All such factors are boosting the demand for medical coveralls globally.

Disposable protective coveralls can be categorized into various levels based on their strength of protection such as - Categories I (minimal risk), II (medium risk), and III (complex PPE). According to EU standards, the medical coveralls can be classified into different types - Type 1, 2, 3, 4, 5, and 6. The compliance requirements for types 1 to 4 include EN 14605 and EN 13982-1 for types 5 and 6. With advancements in technology, compliance requirements also play a key role. Over the years, medical coveralls have evolved from being basic garments into technologically advanced protective gear. As a result of technological advancements, coverall fabrics have also been designed to contain antimicrobial properties. Nanotechnology enabled the creation of nanoparticles embedded in coverall fibers for added protection. The latest medical coverall technology involves ‘smart’ coveralls with built-in sensors to monitor vital signs and alert healthcare professionals of any anomalies.

The medical coveralls category is highly fragmented. The top fifteen to twenty players account for a nominal share of the market. The major players in this category include raw-material suppliers, PPE divisions of major conglomerates, pure-play PPE/medical coveralls manufacturers, and wholesale and retail distributors. Within each segment again, the dynamics vary, which further reduces the bargaining power of suppliers. Manufacturers of coveralls are constantly trying to innovate by employing different types of materials. One instance is the use of SMS fabrics. These fabrics can withstand liquid while being available at competitive prices.

Order your copy of the Medical Coveralls Procurement Intelligence Report, 2023 - 2030, published by Grand View Research, to get more details regarding day one, quick wins, portfolio analysis, key negotiation strategies of key suppliers, and low-cost/best-cost sourcing analysis

The major cost components in the medical coveralls category include raw materials, equipment and machinery, labor, facilities and storage, packaging, freight and transportation, and others. Other costs can include testing and inspection, marketing, insurance, tax, overhead expenses, administrative expenses, etc. Medical coveralls are critical for healthcare workers to prevent and control infection. They are designed to provide out-and-out protection from any kind of exposure.  Hence the selection of the fabric or the raw material must be considered carefully. Synthetic fibers such as nylon 6,6, polyester (PET), polypropylene (PP), and polyethylene (PE) are some of the key fabrics considered to manufacture medical or PPE coveralls.

The majority of disposable coveralls are made of synthetic non-woven fabric, which is a single-use material. However, to improve the longevity and range of applications, woven cloth has witnessed some advancements in recent times. Raw materials form the largest cost component in this category. Factors such as the thickness and weight of the fabric, production or order quantity, single-layer or multi-layer structures, and the type of material chosen can further influence the total cost.

Polypropylene is also another cost-effective material that is widely used. In Q3 2023, PP prices in the North American region fluctuated a lot. The start of the third quarter witnessed a 1 - 2% drop in prices owing to a reduction in feedstock PP prices amid inflationary pressure. The continuous inflation forced consumers to reduce their consumption. As a result, demand remained low amid ample supply, which supported the decline. However, at the end of Q3 PP prices increased by 3 - 4% owing to a 5 - 6% rebound increase in feedstock PP prices and a positive demand from the automotive industry. In October 2023, PP prices in the EU region reached EUR 1,393 per MT. This was a 6% increase from September 2023.

In terms of sourcing intelligence, India, China, Malaysia, and Thailand are the most preferred countries to source medical coveralls. In 2022, China was the largest manufacturer of non-woven fabrics. The majority of medical coveralls use nonwoven fabrics. However, production in India has also ramped up steadily since the pandemic. The PPE industry in India has thrived due to low production costs, easy access to raw materials, and zero border restrictions for trade. India’s regulatory framework has significantly improved since 2021 in the PPE industry. It is common for most large end-user organizations to outsource the production of their medical coveralls.

When procuring medical coveralls, it is important to evaluate the suppliers based on product durability, quality, certifications, and protection parameters. Another key sourcing strategy is to ensure that the production process adheres to regulatory requirements and good manufacturing practices (GMP). For instance, the WHO states that the coveralls (or gowns) must meet AAMI-PB70 requirements. Other important regulatory bodies include the American National Standards Institute (ANSI) and the Association of the Advancement of Medical Instrumentation (AAMI). In the case of the raw material or fabrics used, the different standards include ISO 16604, EN 14126 Annex A, ISO 22611, ISO 22612, EN 16604 or ASTM D1238 for testing purposes, AAMI 4 level compliant coverall, etc.

Browse through Grand View Research’s collection of procurement intelligence studies:

• Medical Waste Disposal Procurement Intelligence Report, 2023 - 2030 (Revenue Forecast, Supplier Ranking & Matrix, Emerging Technologies, Pricing Models, Cost Structure, Engagement & Operating Model, Competitive Landscape)

• Medical Writing Procurement Intelligence Report, 2023 - 2030 (Revenue Forecast, Supplier Ranking & Matrix, Emerging Technologies, Pricing Models, Cost Structure, Engagement & Operating Model, Competitive Landscape)

Medical Coveralls Procurement Intelligence Report Scope

• Medical Coveralls Category Growth Rate: CAGR of 7.4% from 2023 to 2030

• Pricing Growth Outlook: 8% - 9% (Annually)

• Pricing Models: Volume-based and contract-based pricing model

• Supplier Selection Scope: Cost and pricing, past engagements, productivity, geographical presence

• Supplier Selection Criteria: Production capacity, type of material (PP, PET, PE), material thickness, sterility, compliance and safety measures, certifications, testing, operational and functional capabilities, technology used, and others

• Report Coverage: Revenue forecast, supplier ranking, supplier positioning matrix, emerging technology, pricing models, cost structure, competitive landscape, growth factors, trends, engagement, and operating model

Key Companies 

• 3M

• Ansell

• Kimberly-Clark Worldwide, Inc.

• Cardinal Health

• O&M Halyard, Inc.

• Lakeland, Inc.

• Derekduck Industries Corp.

• Plasti Surge Industries

• Winner Medical Co., Ltd.

• DuPont de Nemours Inc.

Brief about Pipeline by Grand View Research:

A smart and effective supply chain is essential for growth in any organization. Pipeline division at Grand View Research provides detailed insights on every aspect of supply chain, which helps in efficient procurement decisions.

Our services include (not limited to):

• Market Intelligence involving – market size and forecast, growth factors, and driving trends

• Price and Cost Intelligence – pricing models adopted for the category, total cost of ownerships

• Supplier Intelligence – rich insight on supplier landscape, and identifies suppliers who are dominating, emerging, lounging, and specializing

• Sourcing / Procurement Intelligence – best practices followed in the industry, identifying standard KPIs and SLAs, peer analysis, negotiation strategies to be utilized with the suppliers, and best suited countries for sourcing to minimize supply chain disruptions

[themarketupdate]

Global Metal Casing Market Will Hit Big Revenues In Future | Biggest Opportunity Of 2024

Latest added Global Metal Casing Market research study by Archive Market Research offers detailed outlook and elaborates market review till 2030. The market Study is segmented by key regions that are accelerating the marketization. At present, the market players are strategizing and overcoming challenges of current scenario; some of the key players in the study are Amazon Web Services, Inc. (Washington, United States),Google LLC (California, United States),IBM Corporation (New York, United States),Microsoft Corporation (Washington, United States),SAP SE (Germany),Yellow Messenger (Karnataka, India),Labiba for Artificial Intelligence LLC (Dubai, United Arab Emirates),Gupshup (Maharashtra, India),SmartBots (Texas, United States),Aivo (Córdoba, Spain),Aifa.AI (Sydney, Australia),Dogtown Media. (California, United States),Peerbits. (Gujarat, India),Master of Code Global. (California, United States),Peltarion (Stockholm, Sweden),Verloop (Karnataka, India),Crisp IM SARL (France),LiveChat, Inc. (Massachusetts, United States),ManyChat, Inc. (San Francisco, United States),Chatfuel (San Francisco, United States),PandoraBots (California, United States),Botscrew (London, UK) etc.  Click for Free Sample Report + All Related Graphs & Charts https://archivemarketresearch.com/report/pet-snacks-and-treats-market-7/sample-report The Global Metal Casing Market size was valued at USD 33.27 billion in 2023 and is projected to reach USD 41.48 billion by 2032, exhibiting a CAGR of 3.2 % during the forecasts period. The latest edition of this report you will be entitled to receive additional chapter / commentary on latest scenario, economic slowdown and COVID-19 impact on overall industry. Further it will also provide qualitative information about when industry could come back on track and what possible measures industry players are taking to deal with current situation. Each of the segment analysis table for forecast period also high % impact on growth. The Global Global Metal Casing segments and Market Data Break Down are illuminated below: {"Component: Platform/Software Development Kit and Services","Deployment: Cloud and On-premises","Application: Website, Contact Centers, Social Media and Mobile Application","Industry: Banking, Financial Services and Insurance (BFSI"}

Have Any Questions Regarding Global Global Metal Casing Market Report, Ask Our Experts@ https://archivemarketresearch.com/report/pet-snacks-and-treats-market-7/enquiry-before-buy This report will give you an unmistakable perspective on every single reality of the market without a need to allude to some other research report or an information source. Our report will give all of you the realities about the past, present, and eventual fate of the concerned Market. Thanks for reading this article, we can also provide customized report as per company’s specific needs. You can also get separate chapter wise or region wise report versions including North America, Europe or Asia.

More Reports:

 https://archivemarketresearch.com/reports/global-metal-casing-market-1957  https://archivemarketresearch.com/reports/anatomic-pathology-market-3060 Contact US : Craig Francis (PR & Marketing Manager) Archive Market Research Unit No. 429, Parsonage Road Edison, NJ New Jersey USA – 08837 Phone: +1 201 565 3262, +44 161 818 8166 sales@advancemarketanalytics.com

[deshpandeisha]

The Growing Field of Animal Ultrasound: A Game Changer in Veterinary Medicine

The global animal ultrasound market size reached USD 286.2 Million in 2020 and is expected to register a revenue CAGR of 8.2% during the forecast period, according to latest analysis by Emergen Research. Increasing number of companion animals and rising demand for pet insurance are some key factors projected to support market revenue growth between 2021 and 2028.

In addition, increasing number of veterinary doctors in developed and developing countries is expected to boost revenue growth of the market going ahead.Increasing number of veterinarians has also resultedin increasingnumberof new treatment facilities, which is expected to boost demand for various treatmentequipment for animals, including animal ultrasound devices.In addition, veterinarians' incomes in developed countries have significantly risen in recent years, and this is strengthening their purchasing power, which is expected to boostadoption of animalultrasound devices in private clinics.

Request a Sample Report with Table of Contents and Figures to click Here: https://www.emergenresearch.com/request-sample/866

Competitive Terrain:

The section on the competitive landscape offers valuable and actionable insights related to the business sphere of the Animal Ultrasound market, covering extensive profiling of the key market players. The report offers information about market share, product portfolio, pricing analysis, and strategic alliances such as mergers and acquisitions, joint ventures, collaborations, partnerships, product launches and brand promotions, among others. The report also discusses the initiatives taken by the key companies to combat the impact of the COVID-19 pandemic.

The leading market contenders listed in the report are:

IDEXX Laboratories, Inc., Carestream Health, Inc., Fujifilm Holdings Corporation, Esaote SpA, GE Healthcare, Heska Corporation, Diagnostic Imaging Systems, Inc., Clarius Mobile Health Corp., DRAMIÑSKI S.A., and Hallmarq Veterinary Imaging Limited

Click to access the Report Study, Read key highlights of the Report and Look at Projected Trends: https://www.emergenresearch.com/industry-report/animal-ultrasound-market

Emergen Research has segmented the global Animal Ultrasound market on the basis of type, application, end-use, and region:

Segments Covered in this report are:

Animal Type Outlook (Revenue, USD Million; 2018–2028)

Large Animals

Small Companion Animals

Imaging Type Outlook (Revenue, USD Million; 2018–2028)

Doppler Imaging

2D Ultrasound Imaging

3D & 4D Ultrasound Imaging

Scanner Type Outlook (Revenue, USD Million; 2018–2028)

Handheld Ultrasound Scanners

Cart-based Ultrasound Scanners

The various regions analyzed in the report include:

North America (U.S., Canada)

Europe (U.K., Italy, Germany, France, Rest of EU)

Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)

Latin America (Chile, Brazil, Argentina, Rest of Latin America)

Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)

Key Objectives of the Report:

Analysis and estimation of the Animal Ultrasound Market size and share for the projected period of 2022-2030

Extensive analysis of the key players of the market by SWOT analysis and Porter’s Five Forces analysis to impart a clear understanding of the competitive landscape

Study of current and emerging trends, restraints, drivers, opportunities, challenges, growth prospects, and risks of the global Animal Ultrasound Market

Analysis of the growth prospects for the stakeholders and investors through the study of the promising segments

Strategic recommendations to the established players and new entrants to capitalize on the emerging growth opportunities

Request Customization as per your specific requirement@ https://www.emergenresearch.com/request-for-customization/866

[industryforecastnews]

U.S. Veterinary Orthopedic Medicine Market Size, Share & Growth Analysis Report, 2030

U.S. Veterinary Orthopedic Medicine Market Growth & Trends

The U.S. veterinary orthopedic medicine market size is expected to reach USD 814.51 million by 2030, registering a CAGR of 7.2% from 2024 to 2030, according to a new report by Grand View Research, Inc. The market is primarily driven by the increasing pet population, adoption of pet insurance, rising prevalence of diseases among animals, and advancements in veterinary medicine.

For instance, in October 2023, the FDA approved Librela (bedinvetmab injection), making it the first monoclonal antibody for treating osteoarthritis-related pain in dogs. In addition, in April 2022, American Regent Animal Health, a division of American Regent, Inc., received FDA approval to extend the shelf life of Adequan Canine and Adequan i.m. The expiration date for both products was increased from 24 months to 36 months from the date of manufacture.

Key players in the veterinary orthopedic medicine market are engaging in strategic initiatives like product launches, collaborations, and acquisitions to make their market presence more prominent, impelling market growth. In September 2022, Zoetis acquired Jurox, a private animal health company specializing in veterinary medicines for livestock and companion animals. The deal, finalized in August 2021, included Jurox's operations in Australia and regional offices in the U.S., Canada, and the UK. Such initiatives are anticipated to drive market growth.

For instance, in October 2023, Athersys, Inc. (ATHX), a cell therapy and regenerative medicine company, entered into a licensing agreement with Ardent Animal Health. With this move, Athersys, known for its work with MultiStem (invimestrocel) in critical care, entered the field of animal health. This collaboration with Ardent, a veterinary biotech firm specializing in regenerative medicine and cancer therapies for animals, highlights Athersys’ commitment to advancing veterinary care.    

Some key impacts of the pandemic and respective lockdowns on the market include dampened growth, decreased sales, supply chain disruptions, and operational challenges. However, the pandemic also propelled concerns over animal health and welfare, strengthened the pet parent and animal bond, and increased pet adoption. Moreover, the market witnessed an improved medicalization rate, pet expenditure, and adoption of pet insurance.

Increasing pet humanization and improved diagnostic rates were other positive impacts of the COVID-19 pandemic on the veterinary sector. In 2021, the market recorded increased demand and sale of veterinary medicines, including orthopedic medicines. In 2022, other macroeconomic uncertainties, such as global recession and cost inflation, adversely impacted the business. However, as the underlying market drivers remain unchanged owing to an increasing prevalence of orthopedic disorders in dogs and horses, the market is estimated to grow notably over the forecast period.

Request a free sample copy or view report summary: https://www.grandviewresearch.com/industry-analysis/us-veterinary-orthopedic-medicine-market-report

U.S. Veterinary Orthopedic Medicine Market Report Highlights

Based on product, pharmaceuticals segment dominated the market, accounting for a share of 46.72% in 2023. Pharmaceutical treatments for orthopedic diseases in pets, such as Non-steroidal Anti-inflammatory Drugs (NSAIDs) and pain relievers, have been widely used and established as effective treatments for managing pain and inflammation. On the other hand, the viscosupplements segment is anticipated to grow at the fastest CAGR of 8.23% during the forecast period

Based on animal type, the market is segmented into dogs and horses. The dogs segment dominated the market, accounting for a share of 51.98% in 2023. It is also anticipated to grow at the fastest CAGR of 7.80% in the coming decade

Based on application, the osteoarthritis segment accounted for the largest share of 60.65% of the market in 2023. The other segment is expected to grow at the fastest CAGR of 9.39% over the forecast period

Based on route of administration, the market is segmented into injectable, oral, and others (e.g., topical). The injectable segment dominated the market, accounting for a share of 60.40% in 2023. The others (e.g., topical) segment is anticipated to grow at the fastest CAGR of 8.22% in the coming decade

On the basis of end-use, veterinary clinics & hospitals segment accounted for the largest share of 53.59% of the market in 2023. The other segment is expected to grow at the fastest CAGR of 8.68% over the forecast period

U.S. Veterinary Orthopedic Medicine Market Segmentation

Grand View Research has segmented the U.S. veterinary orthopedic medicine market based on product, animal type, application, route of administration, and end-use:

U.S. Veterinary Orthopedic Medicine Product Outlook (Revenue, USD Million, 2018 - 2030)

Biologics

Stem Cells

Platelet-Rich Plasma (PRP)

Other Biologics

Viscosupplements

Pharmaceuticals

Steroids

NSAIDS

Others

U.S. Veterinary Orthopedic Medicine Animal Type Outlook (Revenue, USD Million, 2018 - 2030)

Dogs

Small Breeds

Medium Breeds

Large Breeds

Horses

U.S. Veterinary Orthopedic Medicine Application Outlook (Revenue, USD Million; 2018 - 2030)

Osteoarthritis

Degenerative Joint Disease

Others

U.S. Veterinary Orthopedic Medicine Route Of Administration Outlook (Revenue, USD Million, 2018 - 2030)

Injectable

Intra-Muscular

Intra-Articular

Others

Oral

Others

U.S. Veterinary Orthopedic Medicine End-use Outlook (Revenue, USD Million, 2018 - 2030)

Veterinary Hospitals & Clinics

At-home

Others

List of Key Players in the U.S. Veterinary Orthopedic Medicine Market

Zoetis Services LLC

Ardent Animal Health, LLC

Enso Discoveries

VetStem, Inc.

Contura Vet

PetVivo Holdings, Inc.

T-Cyte Therepeutics

Boehringer Ingelheim International GmbH

Arthrex, Inc.

MEDREGO LLC

Nucleus ProVets

Daiichi Sankyo Company, Limited 

Bimeda U.S.

Browse Full Report: https://www.grandviewresearch.com/industry-analysis/us-veterinary-orthopedic-medicine-market-report

[gqresearch24]

Cancer Diagnostics Market Outlook Report 2024-2030: Trends, Strategic Insights and Growth Opportunities | GQ Research

The Cancer Diagnostics market is set to witness remarkable growth, as indicated by recent market analysis conducted by GQ Research. In 2023, the global Cancer Diagnostics market showcased a significant presence, boasting a valuation of USD  18.2 Billion. This underscores the substantial demand for Cancer Diagnostics technology and its widespread adoption across various industries.

Get Sample of this Report at: https://gqresearch.com/request-sample/global-cancer-diagnostics-market/

Projected Growth: Projections suggest that the Cancer Diagnostics market will continue its upward trajectory, with a projected value of USD 45.2 Billion by 2030. This growth is expected to be driven by technological advancements, increasing consumer demand, and expanding application areas.

Compound Annual Growth Rate (CAGR): The forecast period anticipates a Compound Annual Growth Rate (CAGR) of 12 %, reflecting a steady and robust growth rate for the Cancer Diagnostics market over the coming years.

Technology Adoption:

In the Cancer Diagnostics market, technology adoption is crucial for enhancing the accuracy, sensitivity, and speed of cancer detection and monitoring. Laboratories, clinics, and healthcare facilities continually adopt advanced diagnostic technologies, including imaging modalities such as MRI, CT scans, and PET scans, as well as molecular diagnostic techniques like PCR, next-generation sequencing (NGS), and immunoassays. The integration of artificial intelligence (AI) and machine learning algorithms further enhances diagnostic precision and aids in the interpretation of complex data, driving the adoption of innovative technologies for early detection, prognosis, and treatment optimization.

Application Diversity:

Cancer diagnostics encompass a wide range of applications across screening, diagnosis, staging, treatment selection, and monitoring of cancer patients. From screening tests such as mammography and Pap smears for breast and cervical cancer, to biopsy analysis and genetic testing for personalized treatment strategies, the diversity of diagnostic approaches enables tailored management of different cancer types and stages. Additionally, advancements in liquid biopsy techniques facilitate non-invasive detection of circulating tumor cells and cell-free DNA, offering new opportunities for early detection and monitoring of cancer progression and treatment response.

Consumer Preferences:

Consumer preferences in the Cancer Diagnostics market are driven by factors such as accuracy, reliability, convenience, and affordability. Patients and healthcare providers prioritize diagnostic tests that offer high sensitivity and specificity, allowing for early detection and accurate staging of cancer. Preferences also extend to non-invasive or minimally invasive testing methods that minimize patient discomfort and procedural risks. Furthermore, accessibility to diagnostic services, insurance coverage, and reimbursement policies influence consumer decisions, shaping the adoption of specific diagnostic technologies and testing modalities.

Technological Advancements:

Technological advancements drive innovation in cancer diagnostics, enabling the development of novel biomarkers, imaging agents, and diagnostic platforms with improved performance and clinical utility. Breakthroughs in genomics, proteomics, and metabolomics facilitate the identification of cancer-specific biomarkers for early detection and personalized treatment selection. Advanced imaging technologies, such as functional MRI and molecular imaging probes, enhance spatial resolution and sensitivity for tumor localization and characterization. Moreover, the integration of digital pathology, telemedicine, and point-of-care testing solutions expands access to cancer diagnostics in diverse healthcare settings, driving technological advancements towards precision medicine approaches.

Market Competition:

The Cancer Diagnostics market is highly competitive, with numerous players competing to offer innovative diagnostic solutions and services. Established companies, including diagnostic laboratories, medical device manufacturers, and biotechnology firms, leverage their expertise, brand recognition, and global distribution networks to maintain market leadership. Meanwhile, startups and research institutions contribute to market dynamism by developing disruptive technologies and diagnostic assays targeting specific cancer types or molecular pathways. Pricing strategies, regulatory compliance, and strategic partnerships are key determinants of competitive positioning in the market, influencing market share and customer acquisition.

Environmental Considerations:

Environmental considerations in the Cancer Diagnostics market primarily revolve around minimizing the environmental impact of diagnostic procedures and technologies. Efforts to reduce the use of hazardous chemicals and radioactive materials in diagnostic tests contribute to environmental sustainability and occupational safety in healthcare settings. Furthermore, the adoption of digital imaging technologies and electronic health records (EHRs) reduces paper waste and energy consumption associated with traditional film-based imaging and record-keeping practices. As the demand for cancer diagnostics continues to grow, industry stakeholders are increasingly mindful of implementing eco-friendly practices and optimizing resource utilization throughout the diagnostic process..

Regional Dynamics: Different regions may exhibit varying growth rates and adoption patterns influenced by factors such as consumer preferences, technological infrastructure and regulatory frameworks.

Key players in the industry include:

F. Hoffmann-La Roche Ltd.

GE Healthcare

Abbott

Illumina Inc

Qiagen N.V.

Siemens Healthcare GmbH

Thermo Fisher Scientific Inc

Hologic Inc

Koninklijke Philips N.V.

Bio-Rad Laboratories Inc.

The research report provides a comprehensive analysis of the Cancer Diagnostics market, offering insights into current trends, market dynamics and future prospects. It explores key factors driving growth, challenges faced by the industry, and potential opportunities for market players.

For more information and to access a complimentary sample report, visit Link to Sample Report: https://gqresearch.com/request-sample/global-cancer-diagnostics-market/

About GQ Research:

GQ Research is a company that is creating cutting edge, futuristic and informative reports in many different areas. Some of the most common areas where we generate reports are industry reports, country reports, company reports and everything in between.

Contact:

Jessica Joyal

+1 (614) 602 2897 | +919284395731 Website - https://gqresearch.com/

[ana23-jk]

Guide Dogs Pet Insurance Market Size, Data Analysis in 2023-2030

𝙐𝙎𝘼, 𝙉𝙚𝙬 𝙅𝙚𝙧𝙨𝙚𝙮-Market Research Intellect comprehensive research report on the Global Guide Dogs Pet Insurance Market provides a comprehensive overview of the market, allowing stakeholders to gain valuable insights into the current and future dynamics. Our report covers market size and share, market drivers and restraints, current trends, competitive landscape, and future opportunities.

Through this report, stakeholders can gain a greater understanding of the key factors that are likely to shape the market over the forecast period. It will enable them to make informed business decisions and develop strategies for achieving success in the market. Our report offers regional analyses, five-year market forecasts, segmental highlights, and detailed profiles of key market players. This report enables stakeholders to gain detailed insights into the competitive landscape and identify growth pockets in the market. Furthermore, it provides an in-depth analysis for understanding the factors driving market growth, trends in technology, and key strategies adopted by the market players.

Request PDF Sample Copy of Report: (Including Full TOC, List of Tables & Figures, Chart) @ https://www.marketresearchintellect.com/download-sample/?rid=385815&utm_source=Tumblr&utm_medium=027

The research study delves into the prevailing trends embraced by prominent players in the Guide Dogs Pet Insurance markets. It encompasses the adoption of cutting-edge technology, the influence of government funding in Research and Development (R&D), and the growing emphasis on sustainability. Furthermore, our research team has curated essential insights to illuminate the positioning of manufacturers in both domestic and international markets.

The research study comprises profiles of prominent companies actively engaged in the Guide Dogs Pet Insurance market:

Petplan UK (Allianz)

PetSure

Nationwide

Hartville Group

Pethealth

Trupanion

Direct Line Group

Petfirst

Agria

Embrace

The report is structured into chapters, with an introductory executive summary providing historical and estimated global market figures. This section also highlights the segments and reasons behind their progression or decline during the forecast period. Our insightful Guide Dogs Pet Insurance Market report incorporates Porter's five forces analysis and SWOT analysis to decipher the factors influencing consumer and supplier behavior.

Each chapter provides a thorough examination of market subtleties by segmenting the Guide Dogs Pet Insurance Market by application, kind, service, technology, and location. Readers will get a deeper look at market possibilities and dangers thanks to this segment-based study, which also takes into account any political aspects that can have an impact on the industry. Additionally, the research evaluates the risks for new entrants, rates the strength of competitive competition, and closely examines shifting regulatory situations to make precise investment estimates.

Guide Dogs Pet Insurance Market By Type

Lifetime Guarantee

Non-life Protection

More than The Accident

Guide Dogs Pet Insurance Market By Application

Small Breeds

Large Breeds

Guide Dogs Pet Insurance Market by Geography

North America:

Dominated by the United States and Canada.

Mature market with stable growth.

Strong presence of key industry players.

Europe:

Diverse market with varying growth rates.

Western Europe leading in terms of technology adoption.

Eastern Europe showing emerging opportunities.

Asia-Pacific:

Rapidly growing market.

China and India as major growth drivers.

Increasing urbanization and consumer demand.

Latin America:

Mixed market with disparities in economic development.

Brazil and Mexico are key players.

Growing interest in sustainable practices.

Middle East and Africa:

A growing market with untapped potential.

Gulf countries leading in investments.

Focus on infrastructure development.

Get a Discount On The Purchase Of This Report @ https://www.marketresearchintellect.com/ask-for-discount/?rid=385815&utm_source=Tumblr&utm_medium=027

The research study you mentioned appears to focus on several key aspects of the Guide Dogs Pet Insurance markets. Let's break down the points you mentioned:

Current Trends: The study examines the trends currently being adopted by major players in the Guide Dogs Pet Insurance markets. This could include trends related to product innovation, marketing strategies, customer preferences, and more. Understanding these trends can be crucial for businesses to stay competitive.

Use of Cutting-edge Technology: It seems that the research is also exploring how market players are leveraging cutting-edge technology. This could encompass areas such as advanced manufacturing processes, automation, artificial intelligence, and other technological advancements that can give companies a competitive edge.

Government Funding of R&D: Government funding for research and development (R&D) is a significant factor in many industries. It can help drive innovation and support businesses in their quest to develop new products or improve existing ones. The study is likely looking at how much government funding is being allocated to R&D in the Guide Dogs Pet Insurance markets and how companies are utilizing these funds.

Increasing Focus on Sustainability: Sustainability has become a crucial consideration in many industries due to environmental concerns and changing consumer preferences. Companies are increasingly focusing on sustainable practices, such as reducing carbon emissions, using eco-friendly materials, and adopting circular economy principles. The study may assess how prevalent sustainability initiatives are among market players.

Manufacturer's Position in National and International Marketplaces: Understanding a manufacturer's position in both national and international markets is vital for assessing its competitiveness and growth potential. The research likely provides insights into how manufacturers are performing on a global scale and how they compare to their domestic competitors.

>>> Table of Contents

1. Executive Summary

1.1. Key Findings

1.2. Market Overview

1.3. Recommendations

2. Guide Dogs Pet Insurance Introduction

2.1. Research Background

2.2. Objectives of the Study

2.3. Scope and Methodology

2.4. Definitions and Terminology

3. Guide Dogs Pet Insurance Market Overview

3.1. Industry Definition and Classification

3.2. Market Size and Growth

3.3. Market Segmentation

3.4. Market Dynamics

3.4.1. Drivers

3.4.2. Restraints

3.4.3. Opportunities

3.4.4. Challenges

3.5. Porter's Five Forces Analysis

4. Current Trends in the Guide Dogs Pet Insurance Market

4.1. Technological Trends

4.2. Sustainability Initiatives

4.3. Market Strategies of Key Players

4.4. Consumer Preferences

5. Government Funding of R&D

5.1. Government Initiatives and Policies

5.2. Funding Allocation

5.3. Impact on Industry Innovation

6. Manufacturer Profiles

6.1. Company A

6.1.1. Company Overview

6.1.2. Product Portfolio

6.1.3. Financial Performance

6.1.4. Market Presence

6.2. Company B...

6.3. Company C...

7. Guide Dogs Pet Insurance Market Positioning

7.1. National Market Analysis

7.1.1. Market Share

7.1.2. Competitive Landscape

7.2. International Market Analysis

7.2.1. Global Expansion Strategies

7.2.2. Market Performance in Key Regions

8. Future Outlook

8.1. Emerging Trends and Opportunities

8.2. Challenges and Risks

8.3. Future Market Projections

9. Conclusion

10. Appendices

10.1. Data Sources

10.2. Research Methodology

10.3. Glossary of Terms

For More Information or Queries, Visit @ Guide Dogs Pet Insurance Market

About Us: Market Research Intellect

Market Research Intellect is a leading Global Research and Consulting firm servicing over 5000+ global clients. We provide advanced analytical research solutions while offering information-enriched research studies.

Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.

Our research spans a multitude of industries including Energy, Technology, Manufacturing and Construction, Chemicals and Materials, Food and Beverages, etc. Having serviced many Fortune 2000 organizations, we bring a rich and reliable experience that covers all kinds of research needs.

Contact the US:

Mr. Edwyne Fernandes

Market Research Intellect

US: +1 (650)-781-4080

US Toll-Free: +1 (800)-782-1768

[market-insider]

A Comprehensive Report on the Veterinary Antibiotics Market in Europe

The Europe veterinary antibiotics market size is expected to reach USD 1.31 billion by 2030. The rising focus on animal-only antibiotics and ionophores, the launch of new products, and the increasing use of veterinary antibiotics are some of the major factors augmenting the industry's growth. In addition, the rising prevalence and incidence of livestock diseases and concerns regarding zoonoses are further propelling the industry's growth. The COVID-19 pandemic has affected the veterinary antibiotic business operations of key players and resulted in declined financial performance during the initial time.

Europe Veterinary Antibiotics Market Report Highlights

The cattle animal type segment accounted for the largest revenue share in 2021 owing to the easy availability of cattle antibiotics and increased consumption of beef & dairy products

By drug class, the penicillin segment held the largest revenue share in 2021. Penicillinis one of the most commonly sold antibiotic drug classes in Europe for veterinary application

According to the EMA, the overall sales of veterinary penicillin accounted for 31.1% in 2020

The oral solution segment led the market in 2021 owing to the easy & convenient usage of these dosage forms. These solutions are preferably dispensed in the drinking water

The U.K. accounted for the largest revenue share in 2021 and Poland is expected to grow at the fastest CAGR from 2022 to 2030

Key factors contributing to the notable share of the U.K. include the easy availability of veterinary antibiotics and an increase in pet ownership & pet insurance rates

The industry is fairly competitive owing to the presence of major players. Various strategic initiatives implemented by companies are greatly contributing to the growth of the industry

Gain deeper insights on the market and receive your free copy with TOC now @: Europe Veterinary Antibiotics Market Report

The effect of the pandemic with various production and supply chain bottlenecks delayed the delivery of necessary raw materials or active ingredients and postponed certain research & development activities. However, with the easing of restrictions, manufacturers were able to supply antibiotics to meet the necessary veterinary requirements. Few major players have reported significant growth in antibiotic sales despite the pandemic. For instance, Virbac’s bovine antibiotic sales grew from USD 66.98 million in 2020 to USD 79.30 million in 2021. The global concern regarding antibiotic resistance is growing in agriculture and veterinary medicine. Despite the regulatory changes implemented by the European Medicines Agency (EMA) for restriction and ban on routine antibiotic use, the overall sales of veterinary antimicrobial active ingredients have observed significant growth in the past few years.

For instance, according to the EMA, overall veterinary antimicrobial active substance sales grew from 5,282 tonnes in 2019 to 5,562 tonnes in 2020. Furthermore, major players, such as Elanco, have shifted their focus to animal-only antibiotics, as a measure to address antibiotic resistance while also protecting animal health. Key players are implementing various strategic initiatives, such as mergers, partnerships, acquisitions, collaborations, and new product launches, to maintain their competitive edge. For instance, in December 2021, Virbac, in collaboration with Pharmgate, launched Tulissin, an antibiotic solution for swine and cattle with respiratory pathologies. These activities are expected to intensify the competition between major antibiotic manufacturers in the coming years.

[delvenservices]

Animal Antibiotics and Antimicrobials Market Portfolio

Animal Antibiotics and Antimicrobials Market Research Report Information by Delivery Type (Injections, Oral powder, Oral solutions, Premixes, Others), Product Type (Aminocoumarins, Aminoglycosides, Bicyclomycin, etc) and Region (North America, Europe, Asia-Pacific, Middle East and Africa and South America)

The global Animal Antibiotics and Antimicrobials Market is growing with the CAGR of 6.85% in the forecast period of 2021 to 2028 and is expected to reach USD 10.37 billion by 2027.

The term antibiotic or antimicrobial is used for those agents who kill or inhibit the growth of microorganism. The antimicrobials products have significant benefits to the animal and to human food safety. There are researches, which have proven that an increase in the rate of animal illness results in higher rate of human illness. Therefore, livestock dealers depend on animal antibiotics to provide safe food.

The factors such as the growing need for the animal-derived food products, the growing of the prevalence of the zoonotic diseases, the applications of the guidelines for stopping the spread of the animal diseases and the increasing need for the pet insurance and the rising of the animal health expenses are some of the factors that have supported long-term expansion for Animal Antibiotics and Antimicrobials Market.

To Understand Business Strategies, Request for a Sample Report at: https://www.delvens.com/get-free-sample/animal-antibiotics-and-antimicrobials-market-trends-forecast-till-2028

Regional Analysis

North America dominates the animal antibiotics and antimicrobials market because of the increasing number of companion animal healthcare spending, cumulative demand for animal-derived food products, and occurrence of various food-producing. Furthermore, increasing alertness about zoonotic diseases will further boost the growth of the animal antibiotics and antimicrobials market in the region.

Key Players

Zoetis

Boehringer Ingelheim International GmbH

Merck & Co., Inc.

Ceva, Eli Lilly and Company

Bayer AG

Dechra Pharmaceuticals PLC

Virbac, Vetoquinol S.A

Boehringer Ingelheim GmbH

Sanofi

Bioniche Animal Health

Elanco

Fort Dodge Animal Health

Make an Inquiry Before Buying at: https://www.delvens.com/Inquire-before-buying/animal-antibiotics-and-antimicrobials-market-trends-forecast-till-2028

Recent Developments

September 2020, Zoetis announced the launch of Vetscan Imagyst™, a diagnostic platform that uses a combination of image recognition technology, algorithms and cloud-based artificial intelligence (AI) to deliver accurate testing results to the clinic.

June 29, 2021 - Sanofi will invest approximately €400 million annually in a first-of-its kind vaccines mRNA Center of Excellence. The Center will work to accelerate the development and delivery of next-generation vaccines by bringing together approximately 400 dedicated employees integrating end-to-end mRNA vaccine capabilities with dedicated R&D, digital, and chemistry, manufacturing and controls (CMC) teams across sites at Cambridge, MA (US) and Marcy l’Etoile, Lyon (France).

Reasons to Acquire

Increase your understanding of the market for identifying the best and suitable strategies and decisions on the basis of sales or revenue fluctuations in terms of volume and value, distribution chain analysis, market trends and factors

Gain authentic and granular data access for Animal Antibiotics and Antimicrobials Market so as to understand the trends and the factors involved behind changing market situations

Qualitative and quantitative data utilization to discover arrays of future growth from the market trends of leaders to market visionaries and then recognize the significant areas to compete in the future

In-depth analysis of the changing trends of the market by visualizing the historic and forecast year growth patterns

Direct Purchase the Research Report: https://www.delvens.com/checkout/animal-antibiotics-and-antimicrobials-market-trends-forecast-till-2028

Report Scope

Animal Antibiotics and Antimicrobials Market is segmented into delivery type, end user, product type and region.

On the basis of Delivery Type

Injections

Oral powder

Oral solutions

Premixes

On the basis of End-User Industry

Companion animals

Food producing animals

On the basis of Product Type  

Aminocoumarins

Aminoglycosides

Bicyclomycin

Cephalosporins

Fluoroquinolones

Fusidic acid

Macrolides

Penicillin

Phenicols

Sulfonamides

Tetracyclines

On the basis of Region

Asia Pacific

North America

Europe

South America

Middle East & Africa

About Us:

Delvens is a strategic advisory and consulting company headquartered in New Delhi, India. The company holds expertise in providing syndicated research reports, customized research reports and consulting services. Delvens qualitative and quantitative data is highly utilized by each level from niche to major markets, serving more than 1K prominent companies by assuring to provide the information on country, regional and global business environment. We have a database for more than 45 industries in more than 115+ major countries globally.

Delvens database assists the clients by providing in-depth information in crucial business decisions. Delvens offers significant facts and figures across various industries namely Healthcare, IT & Telecom, Chemicals & Materials, Semiconductor & Electronics, Energy, Pharmaceutical, Consumer Goods & Services, Food & Beverages. Our company provides an exhaustive and comprehensive understanding of the business environment.

Contact Us:

UNIT NO. 2126, TOWER B,

21ST FLOOR ALPHATHUM

SECTOR 90 NOIDA 201305, IN

+44-20-8638-5055

 SALES@DELVENS.COM

[rahulp3]

Veterinary Ultrasound Scanners Market 2022 – Latest Innovations, Future Technology, Applications, Driving Factors & Demand over the Worldwide to 2028

Veterinary ultrasound scanners can help to diagnose problems with soft tissues, muscles, blood vessels, tendons, and joints. In the wake of the growing adoption of pets, rising expenditure on pet healthcathe re, prevalence of zoonotic diseases, and animal healthcare insurance, the global veterinary ultrasound scanners market is in for positive growth, in terms of revenue, according to a new report by Future Market Insights..

North America to Dominate Global Veterinary Ultrasound Scanner Market; Western Europe to Follow, APECJ to Present Lucrative Opportunities

Increasing pet adoption and vet care expenditure will boost the veterinary ultrasound market in North America. Western Europe is pegged to be the second largest market for veterinary ultrasound scanners owing to the increasing occurrence of zoonotic diseases and livestock screening for food safety attributable to increased meat consumption. On the other hand, public and private funding along with support programs for vet care will open positive investment prospects for manufacturers of veterinary ultrasound scanners in the Asia Pacific excluding China and Japan.

Discover, Download, and Delve into PDF Samples@https://www.futuremarketinsights.com/reports/sample/rep-gb-3356

Veterinary Ultrasound Scanners to find Increased Adoption for Zoonosis and Pre-Natal Diagnosis

Owing to increased international travel and animal transportation have led to an increase in the number of zoonotic cases- infectious diseases that are spread between humans and animals. Since zoonosis can be severe resulting in the death of human beings, the Centers for Disease Control and Prevention (CDC) is always tracking and reporting such cases. . The major pathogens and diseases associated with zoonotic are anthrax, brucellosis, Chagas disease, Type influenza, Ebola hemorrhagic fever, Rift Valley fever, severe acute respiratory syndrome (SARS) among others. Vector-borne zoonosis coupled with direct and indirect contact of human beings with infected animals increased the chances of contracting zoonotic diseases, in turn, pushing the adoption of veterinary ultrasound scanners.

Governments and vet healthcare organizations are taking initiatives to spread awareness of zoonotic diseases and other travel-acquired diseases. CDC has collaborated with several countries and their human and animal health organizations to conduct ‘One Health Zoonotic Disease Prioritization Workshops’ in a bid to reduce travel-related zoonosis. Moreover, pet owners and animal breeders have increased routine screening and veterinary diagnosis as a prevention method—using imaging devices such as veterinary ultrasound scanners, thereby, positively impacting the overall market growth.

Moreover, since per capita meat and dairy consumption has increased, globally, animal breeders are under immense focus to provide good quality livestock products. For this, regular checking and monitoring of animals are paramount, favoring the growth of the global veterinary ultrasound scanner market during the forecast period.

Animal breeders are adopting ultrasound scanners to assess reproductive scenarios such as early pregnancy diagnosis, multiple pregnancies, and fetal sex determination. Fetal sex determination in equinox and livestock animals allows breeders to replace the cycle of animals and determine the sale value of a breed. However, since the ultrasound scanners used for humans and animals are the same and scanners have to be registered under the PNDT Act 1994, stringent Government regulations decide of fetal gender difficult in countries like China and India, hampering the growth of the veterinary ultrasound scanners market in these regions.

“Companies are introducing technologically advanced ultrasound scanners for animals that can be paired with Android and iOS devices. Lightweight and portable ultrasound scanners are also making their way in the global market that can be used foseveralof species and applications”- Healthcare Industry Analyst, Future Market Insights

Competitive Landscape Insights: Expansion, M&A Strategies to Define Market Growth Roadmap

Key players in the global veterinary ultrasound scanners market include Samsung Medison, IMV Technologies, Mindray, Hitachi, Siemens Healthineers, and Canon Medical Systems. Top manufacturers are likely to focus on strategic alliances and mergers and acquisitions to strengthen their product portfolio and increase the scope for market expansion, thereby, creating opportunities for the players in the veterinary ultrasound market in the untapped regions. The establishment of subsidiaries and marketing alliances would offer geographical expansion prospects to the top players.

Key Segments of Veterinary Ultrasound Scanners Industry Survey

Veterinary Ultrasound Scanners Market by Product Type:

Portable/Hand Held Ultrasound Scanners

Cart Based Ultrasound Scanners

Veterinary Ultrasound Scanners Market by Imaging Technology:

Digital Imaging Technology in Veterinary Ultrasound Scanners

Analog Imaging Technology in Veterinary Ultrasound Scanners

Contrast Imaging Technology in Veterinary Ultrasound Scanners

Veterinary Ultrasound Scanners Market by End User:

Veterinary Ultrasound Scanners in Veterinary Hospitals

Veterinary Ultrasound Scanners in Veterinary Clinics

Veterinary Ultrasound Scanners in Animal Breeding and Farms

Veterinary Ultrasound Scanners Market by Region:

North America Veterinary Ultrasound Scanners Market

Latin America Veterinary Ultrasound Scanners Market

Europe Veterinary Ultrasound Scanners Market

East Asia Veterinary Ultrasound Scanners Market

South Asia & Pacific Veterinary Ultrasound Scanners Market

Middle East & Africa (MEA) Veterinary Ultrasound Scanners Market

[reportsneww]

Neurological Biomarkers Market is anticipated to exhibit a CAGR of 11.9% from 2022 to 2030

Newark, New Castle, USA – Growth Plus Reports’ most recent study examines the Global Neurological Biomarkers Market’s production, prospective uses, demand, key companies, and SWOT analysis.

You may get insights into the TOC, and Statistics for essential facts, information, trends, and competitive landscape information.

Download Free Sample Report Now @ https://www.growthplusreports.com/inquiry/request-sample/neurological-biomarkers-market/8040

The following are the leading companies in the Global Neurological Biomarkers market:

Abbott Laboratories Inc.

Quanterix Corporation

Thermo Fisher Scientific Inc.

Qiagen NV

Bio-Rad Laboratories Inc.

Merck KGaA

Banyan Biomarkers Inc.

Johnson & Johnson

ACOBIOM

Myriad Genetics Inc.

DiaGenic ASA

Olink Biosciences

Growth Plus Reports studies the key trends in each category and sub-segment of the Neurological Biomarkers market, along with Global and regional projections from 2023 to 2031. Our research splits the market into product type and application segments.

SEGMENTATION

GLOBAL NEUROLOGICAL BIOMARKERS MARKET – ANALYSIS & FORECAST, BY TYPE

Genomic

Metabolomic

Proteomic

Imaging

Others

GLOBAL NEUROLOGICAL BIOMARKERS MARKET – ANALYSIS & FORECAST, BY APPLICATION

Alzheimer’s Disease

Parkinson’s Disease

Multiple Sclerosis

Others

GLOBAL NEUROLOGICAL BIOMARKERS MARKET – ANALYSIS & FORECAST, BY END-USER

Hospitals & Laboratories 

Independent Diagnostic Centers 

Research Organizations 

Others

For More Information or Query or Customization visit: https://www.growthplusreports.com/inquiry/customization/neurological-biomarkers-market/8040

Companies may utilize Neurological Biomarkers market report to get insights on market variables and any restraints that may affect the manufacturing of their product. Companies that are expanding abroad require thorough Global market research that includes real market data to assist with their marketing strategy. This Global market Neurological Biomarkers industry study analyzes important market dynamics and provides in-depth information and statistics to help companies flourish. This research report on the Neurological Biomarkers market takes advantage of advanced and professional approaches such as SWOT analysis and GRG Health’s unique GrowthMIX strategy.

This report is useful in addressing various essential issues for market participants, while also supporting them in making investments and leveraging the market opportunities.

Neurological Biomarkers Market TOC: https://www.growthplusreports.com/report/toc/neurological-biomarkers-market/8040

Market segment by Region/Country including: –

-North America (United States, Canada and Mexico) -Europe (Germany, UK, France, Italy, Russia and Spain etc.) -Asia-Pacific (China, Japan, Korea, India, Australia and Southeast Asia etc.) -South America (Brazil, Argentina and Colombia etc.) -Middle East and Africa (South Africa, UAE and Saudi Arabia etc.)

QUICK BUY: https://www.growthplusreports.com/checkout-8040

Browse Latest Healthcare Reports:

Cannabis Drugs Market

Sterilization Wrap Market

Foley Catheters Market

Thrombin Market

Trauma Implants Market

Urinary Drainage Bags Market

Genetic Disease Diagnostics Market

Veterinary Diagnostics Market

Intraoral Scanners Market

Immunodiagnostics Market

Neurodegenerative Disease Drugs Market

Pet Insurance Market

Contact Us:

Manan Sethi Director, Market Insights Email: sales@growthplusreports.com Phone no: +1 888 550 5009 Web: https://www.growthplusreports.com/

About Us Growth Plus Reports is part of GRG Health, a Global healthcare knowledge service company. We are proud members of EPhMRA (European Pharmaceutical Marketing Research Association). Growth Plus portfolio of services draws on our core capabilities of secondary & primary research, market modelling & forecasting, benchmarking, analysis and strategy formulation to help clients create scalable, ground-breaking solutions that prepare them for future growth and success. We were awarded by the prestigious CEO Magazine as “Most Innovative Healthcare Market Research Company in 2020.”

[kritikapatil]

Pet Dog Insurance Market Will Hit Big Revenues In Future | Biggest Opportunity Of 2022

The Latest Released market study on Global Pet Dog Insurance market provides information and useful stats on market structure, size and trends. The report is intended to provide cutting-edge market intelligence and strategic insights to help decision makers take sound investment decisions and identify potential gaps and growth opportunities. Besides, the report also identifies and analyses changing dynamics, emerging trends along with essential drivers, challenges, opportunities and restraints in Pet Dog Insurance market. What’s keeping

Petplan UK (Allianz)

Nationwide (United Kingdom)

Trupanion (United States)

Hartville Group (United States)

Pethealth (Canada)

Petfirst (United States)

Embrace (United Kingdom)

Royal & Sun Alliance (RSA)

Direct Line Group (United Kingdom)

Agria (United Kingdom) Keep Growing in the Market? Benchmark yourself with the strategic moves and latest Market Share and Sizing of Global Pet Dog Insurance market recently published by AMA The global Pet Dog Insurance market is expected to witness high demand in the forecasted period due to the increasing popularity of ownership of dogs across the region. Pet dog insurance is meant to cover the unforeseen veterinary care costs, including veterinary services such as accidental injuries, surgical procedures, and prescribed veterinary medicines. Increasing awareness about pet insurance policies in North America and Rising veterinary service costs will help to boost the global market demand.

The Pet Dog Insurance Market segments and Market Data Break Down by Type (Lifetime Cover, Non-lifetime Cover, Accident-only, Accident & Illness), Application (Small Breed, Large Breed), End Use (Agency, Broker, Bancassurance, Direct Writing)

On the geographical front, the market has been segregated into North America (the United States and Canada), Europe (Germany, France, the United Kingdom, Italy, Spain, Russia and others), Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia and others), Latin America (Brazil, Mexico and others), and Middle East and Africa. What’s Trending in Market: The growing health benefits of Dog ownership

The high demand for innovative dog insurance along with rising veterinary service cost

Market Challenges: The concern related to the high cost of pet insurance policies

Market Opportunities: The low penetration rate

The Surging volume of companion animal

Highlights of Influencing Drivers: Upsurging popularity of pet humanization and rising demand for pet grooming and care products

Presented By

AMA Research & Media LLP

[impossibledeanmakerwombat]

Veterinary Molecular Diagnostics Market Growth, Trends Analysis Report 2032

The global Veterinary Molecular Diagnostics market In 2022, the market for veterinary molecular diagnostics is projected to be worth US$182.1 million. The overall demand for veterinary molecular diagnostics is anticipated to increase at a CAGR of 6.84% between 2022 and 2032, reaching a total of about US$ 352.8 Million by 2032 due to the use of numerous testing panels and the growing consolidation in the veterinary diagnostics industry.

Factors such as the growing pet animal population around the globe, increased animal health spending and advancements in veterinary molecular diagnostics are expected to propel the growth of the veterinary molecular diagnostics market over the analysis period.

Developments in the animal farming sector and changing societal attitude toward pet animals have resulted in an increased demand for fast and reliable diagnostic techniques. Molecular diagnostics possess the potential to address this growing demand.

Request Sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-6742

As of 2018, more than 60% of the US population owned a pet/companion animal. There is an increasing trend of treating pets as family members, which has increased the healthcare demands for veterinary applications. The increasing pet population is one of the reasons for the rising health expenditure on animals, globally.

As per the estimates of the American Pet Products Association, the total American pet industry expenditure is expected to reach USD 75.38 billion by end 2019, up from USD 72.56 billion in 2018. The rise in animal health expenditure is expected to drive the growth of the veterinary molecular diagnostics market, as a significant portion of pet owners are expected to use advanced diagnostic modalities for animals, for various disease conditions.

Furthermore, there is an increase in the livestock population, owing to the huge demand for animal-derived products. This is expected to increase the demand for molecular diagnostic tests in the next coming years.

The Veterinary Molecular Diagnostics Market in the US is expected to accumulate the highest market share of 34.6% in 2022. The United States is expected to dominate the market, attributed to factors, such as rising pet adoption and increasing per capita animal healthcare expenditure. In addition, the rise in the prevalence of various animal diseases and injuries is another major factor that is anticipated to fuel the market growth during the forecast period.

Talk to Analyst @ https://www.futuremarketinsights.com/ask-question/rep-gb-6742

The high growth in the number of veterinary practitioners and rise in income levels in developed economies is amongst the important factors intensifying the growth and demand of veterinary molecular diagnostics market. In addition, the increasing demand for pet insurance and growing animal health expenditure is also contributing to the growth in the global market during the forecast period.

In addition, the increasing demand for animal-derived food products and rising incidence of animal zoonotic diseases are also enhancing the growth of the market. Likewise, the high growth in companion animal population is also lifting the market growth in the forthcoming years.

Key Takeaways from the Market Study

Global Veterinary Molecular Diagnostics Market was valued at US$ 182.1 Mn by 2022-end

From 2017 to 2021, the market demand expanded at a CAGR of 7.3%

By Product Type, the PCR Kits segment of the Veterinary Molecular Diagnostics Market constitutes the bulk of the market with a market share of 50.8%

By Species Type, the Livestock Animals segment dominates the market with a share of 71.0%

From 2022 to 2032, Veterinary Molecular Diagnostics sales are expected to flourish at a CAGR of 6.84%.

By 2032, the market value of Veterinary Molecular Diagnostics is expected to reach US$ 352.8 Mn.

“Factors such as the rising per capita animal healthcare expenditure, coupled with rising pet adoption globally are expected to escalate the growth of the Veterinary Molecular Diagnostics Market over the analysis period”, remarks an FMI analyst.

Last few days to get reports at discounted prices, offer expires soon! Request Discount@ https://www.futuremarketinsights.com/request-discount/rep-gb-6742

Competitive Landscape

Players in the global Veterinary Molecular Diagnostics Market focus on expanding their global reach through various strategies, such as; partnerships, collaborations, and partnerships. The players are also making a significant investment in R&D to add innovations to their products which would help them in strengthening their position in the global market. Some of the recent developments among the key players are:

In April 2021, INDICAL BIOSCIENCE GmbH (Germany) acquired Boehringer Ingelheim’s Svanova product portfolio which helped INDICAL widen its portfolio by adding 25 assays for livestock.

In April 2021, BioChek (Netherlands) opened a new office in Johannesburg, South Africa.

In January 2021, Heska Corporation (US) acquired Lacuna Diagnostics (US), this acquisition strengthened the company’s portfolio of point-of-care digital cytology technology and telemedicine services.

In December 2020, NEOGEN Corporation (US) launched a preventative care DNA screening tool for detecting genetic diseases in dogs.

In November 2020, NEOGEN Corporation (US) collaborated with Transnetyx Inc. (US), this partnership helped NEOGEN to increase its presence in the animal genomics and diagnostics market.

Key Players:

bioMérieux SA

IDEXX Laboratories, Inc.

Neogen Europe, Ltd.

Veterinary Molecular Diagnostics, Inc.

Thermo Fisher Scientific, Inc.

ID-Vet, Qiagen N.V.

[ameymeti2001]

Veterinary Ultrasound Market Worth $520.11 Million by 2030

Veterinary Ultrasound Market Worth $520.11 Million by 2030

According to a new market research report, ‘Veterinary Ultrasound Market by Animal Type [Small, Large (Equine, Farm)], Scanner [Cart-based, Handheld], Technology (2D, 3D/4D, Doppler), Application (Orthopedic, Cardiology, Obstetrics & Gynecology), End User (Clinic, Hospital) - Global Forecast to 2030,’ published by Meticulous Research®, the veterinary ultrasound market is projected to reach $520.11 million by 2030, at a CAGR of 6.1% from 2023 to 2030.

Download Free Report Sample Now @ https://www.meticulousresearch.com/download-sample-report/cp_id=5425

Veterinary ultrasound devices are used for diagnostics and confirmation of the health status of livestock & companion animals. They play an important part in animal disease management and prevention. An ultrasound device also helps in pregnancy diagnosis in animals. The growth of the veterinary ultrasound market is driven by a rise in the adoption of animals, increasing prevalence of zoonotic diseases, technological advancements in ultrasound devices, increasing animal health expenditure & pet insurance in developed countries, and favorable government initiatives. However, the lack of skilled professionals hampers the growth of this market to a notable extent.

Increasing Animal Health Expenditure & Pet Insurance in Developed Countries Supports Veterinary Ultrasound Market Growth

Over the years, veterinary healthcare expenditure has increased. Americans spend a substantial amount on taking care of and feeding their animals. According to the American Pet Products Association, the country spent approximately USD 48.4 billion on pets in 2010. The spending increased to USD 109.6 billion in 2021, more than the combined GDP of the 39 poorest countries. Similarly, according to the Office for National Statistics, in the U.K., expenditure on pets and related products reached USD 6,891.0 million in 2019, from USD 6,233.0 million in 2015. The growth in pet insurance was mainly due to the rising cost of veterinary treatments and services. Thus, the increasing pet insurance is expected to increase veterinary visits, which, in turn, contributes to the growth of the veterinary ultrasound market.

Speak to our Analysts to Understand the Impact of COVID-19 on Your Business: https://www.meticulousresearch.com/speak-to-analyst/cp_id=5425

The global veterinary ultrasound market is segmented by Animal Type [Small Animals, Large Animals (Equine, Farm Animals)], Portability (Handheld Ultrasound Scanner, Cart-based Ultrasound Scanner), Technology (2D Ultrasound, Doppler Ultrasound, 3D/4D Ultrasound), Application (Orthopedics & Musculoskeletal, Cardiology, Obstetrics & Gynecology, and Other Applications), End User (Veterinary Clinics, Hospitals, and Other End Users), and Geography. The study also evaluates industry competitors and analyzes the regional and country-level markets.

Based on animal type, in 2023, the small animals segment is expected to account for the largest share of the veterinary ultrasound market. Factors contributing to the large share of this segment are the increased companion animal population & pet ownerships in developed countries and a rise in the spending on pet healthcare. However, the large animal segment is projected to register the highest CAGR during the forecast period. This segment consists of cows, buffaloes, and horses, among others. The increasing livestock population and rising prevalence of zoonotic diseases in large animals primarily contribute to the growth of this segment.

Based on portability, in 2023, the cart-based ultrasound scanners segment is expected to account for the largest share of the veterinary ultrasound market. However, the handheld ultrasound scanners segment is projected to register the highest CAGR during the forecast period owing to the growing preference for ultrasound scanners for point of care testing. Its portable nature makes it feasible to access animals at remote locations. Additionally, product launches for a wide range of applications also contribute to this segment’s growth.

Quick Buy – Veterinary Ultrasound Market- Global Opportunity Analysis And Industry Forecast (2023-2030), Research Report: https://www.meticulousresearch.com/Checkout/65520182

Based on technology, in 2023, the 2D ultrasound segment is expected to account for the largest share of the veterinary ultrasound market. However, the 3D/4D imaging segment is projected to register the highest CAGR during the forecast period. The advantages of 3D/4D imaging over 2D in terms of diagnosis are contributing to the growth of this segment. Furthermore, 3D/4D imaging enables real-time tissue and organs visualization.

Based on application, in 2023, the cardiology segment is expected to account for the largest share of the veterinary ultrasound market. However, the obstetrics & gynecology segment is expected to register the highest CAGR during the forecast period due to the increasing adoption of ultrasound scanners for pregnancy testing. The demand for dog breeding further increased during the pandemic. Thus, the growing rate of dog breeding and the increasing demand for companion animals are the factors contributing to the growth of this segment.

Based on end user, in 2023, the hospitals segment is expected to account for the largest share of the veterinary ultrasound market. The accessibility to advanced veterinary ultrasound scanners with specific transducers for various applications, the availability of skilled professionals, and the presence of multi-specialty veterinary hospitals are some of the factors contributing to the segment’s large market share.

Based on geography, in 2023, North America is expected to dominate the global veterinary ultrasound market, followed by Europe and Asia-Pacific. Increased public awareness about the diagnosis of animal diseases, a large consumer base, and higher government funding for animal health research contribute to the large share of this market. However, Asia-Pacific is projected to register the highest CAGR during the forecast period.

The report also includes an extensive assessment of the product portfolio, geographic analysis, and key strategic developments adopted by leading market players during 2020–2022. In recent years, the veterinary ultrasound market has witnessed several strategic developments. Some of the key players operating in this market are Esaote S.p.A (Italy), Sonostar Technologies Co. (China), Universal Imaging Inc. (U.S.), FUJIFILM Sonosite, Inc. (U.S.), SOUND (U.S.), Samsung Electronics Co., Ltd. (South Korea), Shenzhen Mindray Animal Medical Technology Co., LTD. (China), Siemens Medical Solutions, Inc. (U.S.), Heska Corporation (U.S.), IMV Imaging Ltd (U.K.), and DRAMIŃSKI S. A. (Poland).

To gain more insights into the market with a detailed table of content and figures, click here: https://www.meticulousresearch.com/product/veterinary-ultrasound-market-5425

Scope of the Report:

Veterinary Ultrasound Market, by Animal Type

Small Animals

Large Animals

Equine

Farm Animals

Veterinary Ultrasound Market, by Portability

Cart-based Ultrasound Scanner

Handheld Ultrasound Scanner

Veterinary Ultrasound Market, by Technology

2D Ultrasound

Doppler Ultrasound

3D/4D Ultrasound

Veterinary Ultrasound Market, by Application

Cardiology

Orthopedics & Musculoskeletal

Obstetrics & Gynecology

Other Applications

Other Applications include oncology, abdominal screening, and ophthalmology

Veterinary Ultrasound Market, by End User

Hospitals

Veterinary Clinics

Other End Users

Other End Users include imaging centers, point-of-care, and surgical centers

Veterinary Ultrasound Market, by Geography

North America

U.S.

Canada

Europe

Germany

France

U.K.

Italy

Spain

Rest of Europe (RoE)

Asia-Pacific

China

Japan

India

Rest of APAC (RoAPAC)

Latin America

Brazil

Mexico

Rest of Latin America (RoLATM)

Middle East & Africa

Download Free Report Sample Now @ https://www.meticulousresearch.com/download-sample-report/cp_id=5425